Table 5

Comorbidity and poor birth outcome for mild microcephaly versus normocephaly

Mortality/morbidityMild microcephaly
(n=2102)
Normocephaly
(n=42 034)
OR
Infants (n)Prevalence per 1000Infants (n)Prevalence per 1000Unadjusted OR
(95% CI)
Adjusted OR*
(95% CI)
In-hospital mortality52.0852.01.18 (0.48 to 2.90)1.21 (0.49 to 3.00)
Preterm (33–36 weeks)8038.4347082.60.45 (0.36 to 0.55)0.45 (0.35 to 0.56)
1 min Apgar score <84521.493922.30.96 (0.71 to 1.30)0.98 (0.72 to 1.33)
5 min Apgar score <862.91413.40.85 (0.38 to 1.93)0.83 (0.37 to 1.90)
Necrotising enterocolitis31.6491.21.23 (0.38 to 3.93)1.26 (0.39 to 4.05)
Intracranial haemorrhage93.21253.01.44 (0.73 to 2.84)1.58 (0.80 to 3.15)
Bronchopulmonary dysplasia10.4210.50.95 (0.13 to 7.08)1.03 (0.14 to 8.04)
Birth hypoxia3516.259414.11.18 (0.84 to 1.67)1.21 (0.85 to 1.71)
Feeding difficulties10355.0224353.40.91 (0.75 to 1.12)0.89 (0.72 to 1.09)
Signs of seizure10.5270.70.74 (0.33 to 5.63)0.76 (0.34 to 5.66)
Sepsis of newborn52.4902.11.11 (0.45 to 2.74)1.09 (0.44 to 2.68)
Respiratory distress syndrome146.343510.30.64 (0.38 to 1.09)0.71 (0.42 to 1.22)
Length of stay >7 days†19793.7391693.21.01 (0.87 to 1.17)1.07 (0.91 to 1.39)
Length of stay (mean±SD, day)3.84±3.663.97±3.21P=0.11
  • *Models contain mild microcephaly (vs normocephaly) as the exposure, and birth issues as outcomes, and are adjusted for infant gender, parity, maternal age, ethnicity, education, TORCH agents, exposure to teratogens, pre-eclampsia, diabetes mellitus and chronic illness.

  • †Infant in-hospital deaths were excluded for the calculation of length of stay.

  • TORCH, Toxoplasma gondii, rubella virus, cytomegalovirus, herpes simplex virus.